Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Samsung Bioepis Co., Ltd. recalls HADLIMA (adalimumab-bwwd) injection

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Lack of Assurance of Sterility.
Products
  • HADLIMA (adalimumab-bwwd) injection
Company
Samsung Bioepis Co., Ltd.
Where it was sold

Distributed only to one warehouse in NJ. with no further distribution

States: New Jersey

Units affected
5,518 packs (11,036 Syringes) 2 syringes/carton)
About this recall
HADLIMA (adalimumab-bwwd) injection, 40mg/0.8 mL, 2 Single-dose Prefilled Syringes per carton, Rx only, Manufactured for: Organon LLC, a subsidiary of ORGANON & Co, Jersey City, NJ 07302, Manufactured by: SAMSUN BIOEPIS Co., Ltd, Incheon, Republic of Korea, NDC 78206-183-01.